Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed May 23, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-05-21$7.81/sh−4,855$37,922→ 376,479 total - Sale
Common Stock
2024-05-21$7.81/sh−2,198$17,169→ 176,374 total(indirect: By Spouse)
Holdings
- 77,592(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Reflects the adjusted total which includes the purchase of 2,349 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
- [F3]Reflects the adjusted total which includes the purchase of 2,636 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
- [F4]The shares are directly held by the Reporting Person's wife.
- [F5]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.